Joyce Chenzi Zhang

Joyce Chenzi Zhang

Auto-generated profile, based on publicly available information

Joyce Chenzi Zhang

Kidney Clinical Research Unit, London Health Sciences Centre, London, Ontario, Canada; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
AAAhmed A. Al-Jaishi
Ahmed A. Al-Jaishi
MOMatthew J. Oliver
Matthew J. Oliver
STSonia M. Thomas
Sonia M. Thomas
CLCharmaine E. Lok
Charmaine E. Lok
JZJoyce C. Zhang
Joyce C. Zhang
LMLouise M. Moist
Louise M. Moist

28 December 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
AAAhmed A. Al-Jaishi
Ahmed A. Al-Jaishi
ALAiden R. Liu
Aiden R. Liu
CLCharmaine E. Lok
Charmaine E. Lok
JZJoyce C. Zhang
Joyce C. Zhang
LMLouise M. Moist
Louise M. Moist
The implementation of patient-centered care requires an individualized approach to hemodialysis vascular access, on the basis of each patient’s unique balance of risks and benefits. This systematic review aimed to summarize current literature on fistula risks, including rates of complications, to assist with patient-centered decision making. We searched Medline from 2000 to 2014 for English-language studies with prospectively captured data on ≥100 fistulas. We assessed study quality and extracted data on study design, patient characteristics, and outcomes. After screening 2292 citations, 43 articles met our inclusion criteria (61 unique cohorts; n>11,374 fistulas). Median complication rates per 1000 patient days were as follows: 0.04 aneurysms (14 unique cohorts; n=1827 fistulas), 0.11 infections (16 cohorts; n>6439 fistulas), 0.05 steal events (15 cohorts; n>2543 fistulas), 0.24 thrombotic events (26 cohorts; n=4232 fistulas), and 0.03 venous hypertensive events (1 cohort; n=350 fistulas). Risk of bias was high in many studies and event rates were variable, thus we could not present pooled results. Studies generally did not report variables associated with fistula complications, patient comorbidities, vessel characteristics, surgeon experience, or nursing cannulation skill. Overall, we found marked variability in complication rates, partly due to poor quality studies, significant heterogeneity of study populations, and inconsistent definitions. There is an urgent need to standardize reporting of methods and definitions of vascular access complications in future clinical studies to better inform patient and provider decision making.

16 February 2018 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
JZJoyce C. Zhang
Joyce C. Zhang
JMJohn Matelski
John Matelski
RGRajiv Gandhi
Rajiv Gandhi
TJTimothy Jackson
Timothy Jackson
DUDavid Urbach
David Urbach
PCPeter Cram
Peter Cram
Background: The “obesity paradox” is a phenomenon described in prior research in which patients who are obese have been shown to have lower postoperative mortality and morbidity compared with normal-weight individuals. The paradox is that clinical experience suggests that obesity is a risk factor for difficult wound healing and adverse cardiovascular outcomes. We suspect that the obesity paradox may reflect selection bias in which only the healthiest patients who are obese are offered surgery, whereas nonobese surgical patients are comprised of both healthy and unhealthy individuals. We questioned whether the obesity paradox (decreased mortality for patients who are obese) would be present in nonurgent hip surgery in which patients can be carefully selected for surgery but absent in urgent hip surgery where patient selection is minimized. Questions/purposes: (1) What is the association between obesity and postoperative mortality in urgent and nonurgent hip surgery? (2) How is obesity associated with individual postoperative complications in urgent and nonurgent hip surgery? (3) How is underweight status associated with postoperative mortality and complications in urgent and nonurgent hip surgery? Methods: We used 2011 to 2014 data from the American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) to identify all adults who underwent nonurgent hip surgery (n = 63,148) and urgent hip surgery (n = 29,047). We used logistic regression models, controlling for covariants including age, sex, anesthesia risk, and comorbidities, to examine the relationship between body mass _index (BMI) category (classified as underweight < 18.5 kg/m2, normal 18.5–24.9 kg/m2, overweight 25–29.9 kg/m2, obese 30–39.9 kg/m2, and morbidly obese > 40 kg/m2) and adverse outcomes including 30-day mortality and surgical complications including wound complications and cardiovascular events. Results: For patients undergoing nonurgent hip surgery, regression models demonstrate that patients who are morbidly obese were less likely to die within 30 days after surgery (odds ratio [OR], 0.12; 95% confidence interval [CI], 0.01-0.57; p = 0.038) compared with patients with normal BMI, consistent with the obesity paradox. For patients undergoing urgent hip surgery, patients who are morbidly obese had similar odds of death within 30 days compared with patients with normal BMI (OR, 1.18; 95% CI, 0.76-1.76; p = 0.54). Patients who are morbidly obese had higher odds of wound complications in both nonurgent (OR, 4.93; 95% CI, 3.68-6.65; p < 0.001) and urgent cohorts (OR, 4.85; 95% CI, 3.27-7.01; p < 0.001) compared with normal-weight patients. Underweight patients were more likely to die within 30 days in both nonurgent (OR, 3.79; 95% CI, 1.10-9.97; p = 0.015) and urgent cohorts (OR, 1.47; 95% CI, 1.23-1.75; p < 0.001) compared with normal-weight patients. Conclusions: Patients who are morbidly obese appear to have a reduced risk of death in 30 days after nonurgent hip surgery, but not for urgent hip surgery. Our results suggest that the obesity paradox may be an artifact of selection bias introduced by careful selection of the healthiest patients who are obese for elective hip surgery. Surgeons should continue to consider obesity a risk factor for postoperative mortality and complications such as wound infections for both urgent and nonurgent surgery. Level of Evidence: Level III, therapeutic study.

18 March 2014 in Hemodialysis International
Verified
Journal Article
Closed access
PDF file
JZJoyce C. Zhang
Joyce C. Zhang
AAAhmed A. Al‐Jaishi
Ahmed A. Al‐Jaishi
YNYingbo Na
Yingbo Na
ESEric de Sa
Eric de Sa
LMLouise M. Moist
Louise M. Moist

1 March 2015 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
AAAhmed A. Al-Jaishi
Ahmed A. Al-Jaishi
CLCharmaine E. Lok
Charmaine E. Lok
AGAmit X. Garg
Amit X. Garg
JZJoyce C. Zhang
Joyce C. Zhang
LMLouise M. Moist
Louise M. Moist
Background and objectives In Canada, approximately 17% of patients use an arteriovenous access (fistula or arteriovenous graft) at commencement of hemodialysis, despite guideline recommendations promoting its timely creation and use. It is unclear if this low pattern of use is attributable to the lack of surgical creation or a high nonuse rate. Design, setting, participants, & measurements Using large health care databases in Ontario, Canada, a population-based cohort of adult patients (≥18 years old) who initiated hemodialysis as their first form of RRT between 2001 and 2010 was studied. The aims were to (1) estimate the proportion of patients who had an arteriovenous access created before starting hemodialysis and the proportion who successfully used it at hemodialysis start, (2) test for secular trends in arteriovenous access creation, and (3) estimate the effect of late nephrology referral and patient characteristics on arteriovenous access creation. Results There were 17,183 patients on incident hemodialysis. The mean age was 65.8 years, 60% were men, and 40% were referred late to a nephrologist; 27% of patients (4556 of 17,183) had one or more arteriovenous accesses created, and the median time between arteriovenous access creation and hemodialysis start was 184 days. When late referrals were excluded, 39% of patients (4007 of 10,291) had one or more arteriovenous accesses created, and 27% of patients (2724 of 10,291) used the arteriovenous access. Since 2001, there has been a decline in arteriovenous access creation before hemodialysis initiation. Women, higher numbers of comorbidities, and rural residence were consistently associated with lower rates of arteriovenous access creation. These results persisted even after removing patients with <6 months nephrology care or who had AKI 6 months before starting hemodialysis. Conclusions In Canada, arteriovenous access creation before hemodialysis initiation is low, even among patients followed by a nephrologist. Better understanding of the barriers and influencers of arteriovenous access creation is needed to inform both clinical care and guidelines.

1 October 2015 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
JZJoyce C. Zhang
Joyce C. Zhang
AAAhmed Al-Jaishi
Ahmed Al-Jaishi
JPJeffery Perl
Jeffery Perl
AGAmit X. Garg
Amit X. Garg
LMLouise M. Moist
Louise M. Moist